Recent Progress in the Discovery and Development of Monoclonal Antibodies against Viral Infections
Monoclonal antibodies (mAbs), the new revolutionary class of medications, are fast becoming tools against various diseases thanks to a unique structure and function that allow them to bind highly specific targets or receptors. These specialized proteins can be produced in large quantities via the hy...
Main Authors: | Pardis Mokhtary, Zeinab Pourhashem, Akram Abouei Mehrizi, Claudia Sala, Rino Rappuoli |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-08-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/10/8/1861 |
Similar Items
-
Leading Edge: Intratumor Delivery of Monoclonal Antibodies for the Treatment of Solid Tumors
by: Ester Blanco, et al.
Published: (2023-01-01) -
Discovery-stage identification of drug-like antibodies using emerging experimental and computational methods
by: Emily K. Makowski, et al.
Published: (2021-01-01) -
An update to monoclonal antibody as therapeutic option against COVID-19
by: Paroma Deb, et al.
Published: (2021-04-01) -
Therapeutic Application of Monoclonal Antibodies in Pancreatic Cancer: Advances, Challenges and Future Opportunities
by: Gustavo A. Arias-Pinilla, et al.
Published: (2021-04-01) -
Neutralizing monoclonal antibodies for COVID-19 treatment and prevention
by: Juan Pablo Jaworski
Published: (2021-03-01)